Objectives The PLATO (Platelet Inhibition and Patient Outcomes) angiographic substudy sought to compare the efficacy of ticagrelor versus clopidogrel with respect to angiographic outcomes before and after PCI in the setting of acute coronary syndrome
BACKGROUND Extensive coronary artery disease (CAD) is associated with higher risk. In this substu...
BACKGROUND We aimed to describe the effects of ticagrelor versus clopidogrel on stent thrombosis ...
Evaluation of: Levin LA, Wallentin L, Bernfort L et al. Health-related quality of life of ticagrelor...
ObjectivesThe PLATO (Platelet Inhibition and Patient Outcomes) angiographic substudy sought to compa...
ObjectivesThe PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy aimed to compare th...
ObjectivesThe PLATO (Platelet Inhibition and Patient Outcomes) angiographic substudy sought to compa...
Background-Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background-We sought to evaluate the effect of potent platelet inhibition after acute coronary syndr...
Background-We sought to evaluate the effect of potent platelet inhibition after acute coronary syndr...
AbstractObjectivesThe purpose of this study was to compare the effects of ticagrelor versus clopidog...
ObjectivesThis study sought to report the treatment effect of ticagrelor on myocardial infarction (M...
Aims The optimal platelet inhibition strategy for ACS patients managed without revascularization is ...
Objectives This study sought to report the treatment effect of ticagrelor on myocardial infarction (...
BACKGROUND Extensive coronary artery disease (CAD) is associated with higher risk. In this substu...
BACKGROUND We aimed to describe the effects of ticagrelor versus clopidogrel on stent thrombosis ...
Evaluation of: Levin LA, Wallentin L, Bernfort L et al. Health-related quality of life of ticagrelor...
ObjectivesThe PLATO (Platelet Inhibition and Patient Outcomes) angiographic substudy sought to compa...
ObjectivesThe PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy aimed to compare th...
ObjectivesThe PLATO (Platelet Inhibition and Patient Outcomes) angiographic substudy sought to compa...
Background-Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background—Aspirin and clopidogrel are recommended for patients with acute coronary syndromes (ACS) ...
Background-We sought to evaluate the effect of potent platelet inhibition after acute coronary syndr...
Background-We sought to evaluate the effect of potent platelet inhibition after acute coronary syndr...
AbstractObjectivesThe purpose of this study was to compare the effects of ticagrelor versus clopidog...
ObjectivesThis study sought to report the treatment effect of ticagrelor on myocardial infarction (M...
Aims The optimal platelet inhibition strategy for ACS patients managed without revascularization is ...
Objectives This study sought to report the treatment effect of ticagrelor on myocardial infarction (...
BACKGROUND Extensive coronary artery disease (CAD) is associated with higher risk. In this substu...
BACKGROUND We aimed to describe the effects of ticagrelor versus clopidogrel on stent thrombosis ...
Evaluation of: Levin LA, Wallentin L, Bernfort L et al. Health-related quality of life of ticagrelor...